CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for DelSite, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

DelSite, Inc.
2001 Walnut Hill Lane
Phone: (972) 518-1300p:972 518-1300 Irving, TX  75038  United States Ticker: DSIIQDSIIQ
On 3/12/2012, Case #09-31981, filed in the U.S. Bankruptcy Court for the Northern District of Texas (Dallas) was closed.
This company is no longer actively traded on any major stock exchange.
Business Summary
DelSite, Inc., formerly Carrington Laboratories, Inc., is a research-based biopharmaceutical, medical device, raw materials and nutraceutical company engaged in the development, manufacturing and marketing of carbohydrates and other natural product therapeutics. Its segments include Medical Services Division, Consumer Services Division and DelSite Biotechnologies, Inc. (DelSite). It sells prescription and nonprescription medical products through the Medical Services Division and provides manufacturing services to customers in medical markets. Through the Consumer Services Division, it sells consumer and raw material products and provides product development and manufacturing services to customers in the cosmetic and nutraceutical markets. On July 31, 2008, it sold the Carrington wound care division to Medline Industries. In April 2009, the Company announced that it filed for bankruptcy protection under Chapter 7 of the United States Bankruptcy laws and the Company will be liquidated.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/200812/31/2007YesYesYes--

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Carlton E.Turner 67 12/31/2008 5/1/1989
Acting President, Acting Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary Robert W.Schnitzius 51 1/1/2009 11/1/1997
Director Ronald R.Blanck 69 6/1/2003 6/1/2003
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Caraloe, Inc.
Carrington Laboratories International, Inc.
Carrington Laboratories, Inc.
5 additional Business Names available in full report.

General Information
Number of Employees: 229 (As of 12/31/2007)
Outstanding Shares: 11,169,241 (As of 11/11/2008)
Shareholders: 862
Stock Exchange: OTC
Federal Tax Id: 751435663
Fax Number: (972) 518-1020


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023